Clinical study on safety of SPECT probe targeting GLP-1 receptor
Not Applicable
- Conditions
- healthy subjects
- Registration Number
- JPRN-UMIN000026463
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1)BMI<18.5 or 30.0< 2)complication severe renal dysfunction pancreatic tumor pancreatitis 3)past history pancreatitis pancreatic disease 4)unsuitable for and contraindication to Exenatide 5)alcohol intolerance 6)Inadequate patient judged by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of frequency of adverse event and severity
- Secondary Outcome Measures
Name Time Method Probe accumulation into pancreas